Page 8 - Indian Pharma Companies

Clinically tried and tested: Bharat Biotech boss Ella wins Covaxin fight

Covaxin was India's first indigenously developed vaccine to be approved, controversially under "clinical trial mode" in the first week of January

European Union drug regulator audits manufacturing site of Serum Institute

AstraZeneca Chief Executive (CEO) Pascal Soriot has indicated that the company may look at factories outside of the EU to meet the supply commitments.

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

India's economic revival: PLI scheme likely to take center stage

16 schemes from equal numbers of companies have been approved to boost local production, value addition and, consequently, export of mobile phones.

Bharat Biotech to have phase 3 efficacy data for Covaxin in 2 weeks

The restricted emergency use allowed by the regulator was based on phase 2 safety and immunogenicity studies, as well as data from monkey trials

Serum Institute to export Covid-19 vaccine to 25-30 countries on Tuesday

Bharat Bio says keen to follow, have capacity of 40 mn doses a month

Dr Reddy's applies for emergency use approval for Sputnik V vaccine

Aims to launch the vaccine in March if regulator approval comes through

Covid-19 drugs among top-selling brands for pharma players in India

Data shows that cumulative sales of remdesivir was Rs 510 crore in January 2021, while for favipiravir it was Rs 471 crore

PLI scheme may trigger investments worth Rs 50,000 crore into pharma sector

According to the people, 86 companies have applied to start production of bulk drugs listed under the PLI scheme so far, said sources

Sales of Ivermectin, drug to treat parasitic infections, jump fourfold

Mumbai-based pulmonologist Dr Agam Vora said in the first few months of the pandemic, the line of treatment was not established

Market reacts negatively to Biocon's weaker results, exit of biologics' MD

Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"

India to start Covid-19 vaccine exports on Wednesday, says report

The foreign ministry said shipments would start on Wednesday following requests from "neighbouring and key partner countries"

India and smug mediocrity

Indian democracy is equating excellence with elitism

Covid vaccination drive: India well prepared to store, distribute vaccines

India has about 29,000 cold chain points, 1.6 million shipper boxes, 76,000 cold chain equipment, 700 reefer vans and 55,000 cold chain handlers

Bharat Biotech concludes recruitment for Covaxin's phase 3 study

Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee

Bharat Biotech: A journey that started with a scientist's return to India

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race

It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner

Our goal now is to provide it globally: Bharat Biotech on Covaxin approval

Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine-- Covaxin-- is a giant leap for innovation and novel product development in India

The story behind the rise of Serum Institute, world's vaccine factory

Today, SII sells about 1.5 billion vaccine doses every year to 170 countries and is the largest producer of vaccines globally by number of doses

Zydus Cadila receives drug regulator's nod for NAFLD medicine in India

ZydusCadila said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the country